Separately, Zacks Investment Research cut shares of Vitamin Shoppe from a buy rating to a hold rating in a research note on Friday, November 8th.
Shares of NYSE VSI opened at $6.49 on Tuesday. Vitamin Shoppe has a 12-month low of $3.32 and a 12-month high of $8.26. The firm has a market capitalization of $156.16 million, a price-to-earnings ratio of 24.96 and a beta of 1.58. The company has a current ratio of 1.16, a quick ratio of 0.21 and a debt-to-equity ratio of 2.34. The firm has a 50 day moving average of $6.49 and a 200 day moving average of $5.51.
About Vitamin Shoppe
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Featured Article: Insider Trading – What You Need to Know
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.